Objective: Black patients undergoing carotid endarterectomy (CEA) in the United States are more often symptomatic at presentation and have more comorbidities compared with white patients. However, the impact of race on outcomes after CEA is largely unknown.
Despite ongoing efforts to reduce racial disparities in health care, the racial gap in patients undergoing carotid endarterectomy (CEA) remains. Eligible black patients are less likely to undergo CEA, less often receive appropriate preoperative imaging studies, and experience a delay between diagnosis and procedure. [1] [2] [3] In addition, black patients have a higher disease burden, more often are symptomatic at presentation, and are more likely to have a stroke than a transient ischemic attack (TIA) as their presenting symptom. 4 However, the impact of race on outcomes after CEA is conflicting. Whereas some early studies reported a higher risk for postoperative complications after CEA in black patients, [5] [6] [7] others found no association between race and stroke or mortality after CEA. 8, 9 However, most were limited by a small sample size or lacked detailed information on factors such as insurance type and hospital quality, which among patients undergoing abdominal aneurysm repair accounted for one-fourth of racial differences in outcomes. 10 Therefore, we sought to evaluate the association of race with early and long-term outcomes after CEA, using a contemporary cohort of CEA.
METHODS
The Beth Israel Deaconess Medical Center Institutional Review Board approved this project and waived the need for informed consent for the use of deidentified data in the registry.
Patients and registry. We performed a retrospective analysis of all CEA patients prospectively included in the Vascular Quality Initiative (VQI) registry between January 2012 and March 2017. The VQI is a North American collaboration between 417 U.S. and three Canadian centers, divided into 18 deidentified regional vascular quality groups, comprising >3200 physicians. The goal of the VQI is to assess quality of care and to guide future quality improvements by monitoring >200 predefined variables on patient demographics, operative details, and clinical outcomes in addition to collecting perioperative and 1-year follow-up data. 11, 12 The VQI performs annual audits of discharge claims for each participating hospital to ensure that each physician entered all of the eligible procedures, thus preventing selection bias. Moreover, the VQI retrieves mortality data from the Social Security Death Index, which allows reliable perioperative mortality and long-term survival analysis. 13 End points and definitions. Our exposure variable was race, classified as non-Hispanic white and non-Hispanic black, hereafter referred to as white and black. We defined symptomatic patients as those having a preprocedural ipsilateral neurologic event, which included any ipsilateral hemispheric or ocular TIA or any ipsilateral stroke. 12, 14 We classified all patients with a preoperative hemoglobin level <11 g/dL as having moderate anemia, based on the World Health Organization guideline. 15 We assessed center and surgeon volume by stratification into volume quintiles based on their corresponding average annual volume of procedures. Our primary end point was any in-hospital stroke or any death within 30 days, hereafter referred to as perioperative stroke/death. Secondary end points were 30-day mortality; long-term survival; in-hospital events of stroke, myocardial infarction (MI), and cranial nerve injury (CNI); any return to the operating room; length of stay (LOS) >2 days; and any failed discharge to home. The definition of stroke included any new motor or sensory loss, speech abnormality, or documentation of any other neurologic symptom related to the right or left hemisphere, lasting at least 24 hours. MI included electrocardiographic changes characteristic for MI or elevated troponin levels. The VQI defined CNI as any CNI that began after the CEA and persisted until the time of discharge. We calculated LOS as the number of days between surgery and discharge. We classified failed discharge home as any patient who was admitted from home but discharged to a place other than home.
Statistical analysis. We presented categorical variables as counts and percentages and continuous variables as mean 6 standard deviation or median and interquartile range, where appropriate. To assess differences between black and white patients in our univariate analysis, we used c 2 and Fisher exact tests for categorical variables and Student t-test and Mann-Whitney U test for continuous variables, where appropriate. To evaluate the timing of CEA in symptomatic patients, we stratified symptomatic patients as those operated on <2 weeks vs those operated on $2 weeks after the index neurologic symptom.
Using multilevel logistic regression analysis, which allowed random variation at the center level, we assessed the impact of race on perioperative outcomes, after adjustment for significant predictors and confounders, according to the methodology of purposeful selection, which combines known risk factors with significant confounders and covariates with a P < .2 on univariate screen. 16 In addition, we used multilevel logistic regression to identify independent risk factors for perioperative stroke/death, regardless of patients' race, after which we evaluated whether the association between these factors and perioperative stroke/death differed significantly between black and white patients, using an interaction term.
For our survival analysis, we performed multivariable Cox regression. This adjusted for significant predictors and confounders of long-term survival, which, based on the Schoenfeld residuals test, included time-dependent variables for nonproportional covariates in the model. We used our Cox regression model to graph the survival functions for black and white patients.
Within our multilevel logistic and Cox regression analyses, we assigned dummy variables to account for patients missing data on insurance status (5.6% missing), ambulatory status (5.7% missing), or contralateral carotid 
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RESULTS
Baseline characteristics. Of the 2909 black patients, 983 (34%) were symptomatic, whereas of the 54,713 white patients, 16 ,132 (30%) were symptomatic (P < .001). Overall, regardless of symptom status, black patients were younger; they were more likely to be female, on selfpay or Medicaid insurance, functionally dependent, and current smokers and to have insulin-dependent diabetes mellitus (IDDM), congestive heart failure (CHF), hypertension, anemia, end-stage renal disease, or a prior amputation; but they were less likely to have chronic obstructive pulmonary disease or a prior coronary intervention and to be operated on by a high-volume surgeon or in a high-volume center ( Table I , A). Moreover, symptomatic black patients were more likely operated on <2 weeks vs $2 weeks of their index neurologic symptom compared with symptomatic white patients (47% vs 40%; P < .001). Similarly, among patients with a preprocedural ipsilateral stroke, black patients were more likely operated on within 2 weeks than white patients were (48% vs 42%; P ¼ .004). However, timing of CEA (ie, <2 weeks vs $2 weeks) was more comparable among preprocedural ipsilateral TIA patients (44% vs 39%; P ¼ .07).
Perioperative details. Overall, regardless of symptom status, operation time was longer in black patients, and although black patients were less often discharged on acetylsalicylic acid (ASA), they were more often discharged on dual antiplatelet therapy (ie, ASA and P2Y 12 receptor antagonist; Table I, B) . Postoperative blood pressure control treated with intravenous (IV) medication was more common in black patients.
In addition, among symptomatic patients, black patients more often received an eversion type of CEA. Among those undergoing conventional CEA, black patients were less likely to have patch closure (Table I . Even after we excluded all patients with a recorded in-hospital complication in the VQI (ie, any stroke, MI, CNI, new dysrhythmia, new CHF, wound infection, reperfusion symptoms, and return to operating room), black patients experienced higher rates of LOS >2 days and failed discharge home (all P < .001). For long-term survival analysis, 79% of patients were available after 1 year, with 56% after 2 years and 34% after 3 years. Black and white patients experienced similar unadjusted long-term survival at 3 years (93% vs 93%; P ¼ .7).
Multilevel logistic regression for perioperative outcomes. After adjustment for age, sex, insurance status, preprocedural ipsilateral stroke, timing of CEA after index neurologic symptom, ambulatory status, IDDM, coronary artery disease, CHF, moderate anemia, end-stage renal failure, contralateral carotid occlusion, center and surgeon volume, preoperative angiography, urgent procedure, general anesthesia, CEA type (ie, conventional with vs without patch vs eversion), shunt use, IV dextran use, perioperative hypotension or hypertension with IV medication, and discharge medication (ie, ASA, statin), black race was not associated with a higher risk of perioperative stroke/death (odds ratio [OR], 1.0; 95% confidence interval [CI], 0.8-1.3; P ¼ .99; Table III), 30-day mortality (OR, 0.9; 95% CI, 0.6-1.5; P ¼ .7), or any stroke (OR, 1.0; 95% CI, 0.7-1.4; P ¼ .8) or with MI, CNI, or any return to the operating room. Black race was associated with LOS >2 days (OR, 1.6; 95% CI, 1.4-1.8; P < .001) and failed discharge home (OR, 1.5; 95% CI, 1.3-1.8; P < .001).
Independent predictors of perioperative stroke/ death. Table IV shows independent predictors of perioperative stroke/death and differences between black and white patients in the associated risk of these factors. The most notable independent risk factors for perioperative stroke/death were hypotension treated with IV medication (OR, 3.0; 95% CI, 2.6-3.6; P < .001), hypertension treated with IV medication (OR, 2.6; 95% CI, 2.3-3.1; P < .001), and contralateral carotid occlusion (OR, 1.8; 95% CI, 1.4-2.3; P < .001), whereas undergoing a procedure $2 weeks after index neurologic symptom (OR, 0.8; 95% CI, 0.6-1.0; P ¼ .03), an elective procedure (OR, 0.6; 95% CI, 0.5-0.7; P < .001), and being discharged on statin (OR, 0.6; 95% CI, 0.5-0.7; P < .001) or ASA (OR, 0.4; 95% CI, 0.3-0.5; P < .001) were protective of perioperative stroke/death.
Only the associated risk of hypotension treated with IV medication differed significantly between black and white patients (black: OR, 6.2 [95% CI, 3.5-11.0; P < .001]; white: OR, 2.6 [95% CI, 2.3-3.0; P < .001]; interaction P ¼ .01). However, the prevalence of most risk factors associated with perioperative stroke/death was higher in black patients than in white patients (Table IV) . (Continued on next page)
Multivariable Cox regression for long-term survival. Black patients experienced significantly better long-term survival than white patients (hazard ratio, 0.8 95% CI, 0.7-0.9; P ¼ .01; Fig) after adjustment for age, sex, insurance status, preprocedural ipsilateral stroke, ambulatory status, smoking, IDDM, coronary artery disease, CHF, chronic obstructive pulmonary disease, moderate anemia, glomerular filtration rate <60 mL/min, contralateral carotid occlusion, prior noncardiac bypass procedure, prior neck irradiation, prior contralateral CEA, center and surgeon volume, CEA type (ie, conventional with vs without patch vs eversion), perioperative hypotension or hypertension treated with IV medication, and discharge medication (ie, ASA, statin), including time-dependent covariates for preprocedural ipsilateral stroke, perioperative hypotension or hypertension treated with IV medication, age, and discharge medication (ie, ASA, statin).
DISCUSSION
This study demonstrates that black patients, regardless of symptom status, experience rates of perioperative stroke/death, 30-day mortality, in-hospital events (stroke, MI, CNI), and unadjusted long-term survival after CEA similar to those of white patients, despite racial disparities in comorbidities, vascular risk factors, insurance status, hospital and surgeon volume, time to surgery after index neurologic symptom, patch angioplasty, and discharge medication. Moreover, after adjustment, which in part accounted for the identified racial disparities, black patients experienced better long-term survival compared with white patients.
Several prior studies evaluated the impact of race on outcomes after CEA but reported conflicting results, probably related to limitations of their data. Overall, most were limited by a small sample of black patients, with very small event numbers. 5, 6, 8, 17, 18 In addition, those using administrative or Medicare data lacked information on preprocedural stroke or TIA laterality, impeding a reliable classification of symptomatic patients. 5, 7, 9 This could result in biased racial comparisons among CEA patients as black patients are more likely to be symptomatic and more often have an ipsilateral stroke as their presenting symptom. Moreover, the three studies that used the American College of Surgeons National Surgical Quality Improvement Program registry lacked detailed information on the degree of carotid artery stenosis, medication, hospital or surgeon volume, and insurance status. 8, 17, 19 In addition, the nontargeted National Surgical Quality Improvement Program may misclassify symptom status by including contralateral symptoms and those occurring >6 months before the procedure, impeding the overall analysis. 20, 21 However, more worrisome, they differed in their identified effect of race on outcomes after CEA; two found no association between race and stroke or death, 8, 21 whereas one did find an association between black race and 30-day mortality. 18 Despite comparable perioperative complication rates between black and white patients in our study, black patients experienced longer LOS and more failed discharges to home, which might reflect differences in socioeconomic factors and social networks in combination with their overall higher disease burden. The higher prevalence of risk factors for perioperative stroke/death among black patients compared with white patients illustrates the extent of racial disparities among CEA patients. The high prevalence of symptomatic patients among the black population, of whom most have a stroke as their presenting symptom, might be related to their overall higher vascular disease burden, differences in antiplatelet medication, or a potential delay between diagnosis and intervention. 3, 4 Interestingly however, contrary to previous reports, we found that symptomatic black patients more often underwent revascularization within 2 weeks of their index neurologic symptom compared with symptomatic white patients. This could, in part, explain the comparable stroke rates in black and white patients, despite the higher prevalence of vascular risk factors in black patients, as delayed carotid revascularization has been shown to increase the risk of preoperative stroke recurrence. 22 Unfortunately, assessing preoperative stroke recurrence is not possible in the VQI because only the index neurologic symptom is captured. On the other hand, a delayed CEA (ie, $2 weeks vs <2 weeks) after the index neurologic symptom resulted in a lower perioperative stroke/death risk, but at a likely cost of a higher risk of preoperative stroke recurrence. As any racial inequality in time to surgery among symptomatic CEA patients is unwarranted, this represents an opportunity for future quality improvement efforts. In addition, some have suggested that black patients might experience a different response to certain medical conditions, such as hypertension. [23] [24] [25] This could explain the difference between black and white patients in rates of postoperative hypotension and hypertension treated with IV medication, in addition to the higher associated risk of hypotension treated with IV medication in black patients. However, it could also be related to less well controlled preprocedural blood pressure among black patients; unfortunately, information about preprocedural blood pressure is not captured by the VQI. Regardless, we do recommend future research to focus on accurate blood pressure measurement and control in black and white patients undergoing CEA to gain insight into racial differences in the hemodynamic response to carotid revascularization as well as potentially reducing the associated risk. 26 Moreover, among symptomatic patients, black patients more often received CEA without patch closure than white patients did. This observation is worrisome as in prior research, patch angioplasty, compared with primary closure, decreased the risks of perioperative death/stroke, long-term stroke, and restenosis. 27, 28 Hence, guidelines currently recommend patch angioplasty over primary closure for CEA patients. Efforts should be made to address these racial disparities in surgical care between black and white CEA patients. The better adjusted long-term survival for black patients after CEA seems counterintuitive. However, because our multivariable Cox regression model adjusted for racial disparities, such as comorbidities, vascular risk factors, insurance status, hospital and surgeon volume, and surgical care, it in part diminished the impact of these racial disparities on outcomes after CEA and better reflects the impact of race, by itself, on outcomes after CEA. Moreover, prior work by our group as well as two other studies identified a similar adjusted survival benefit in black patients undergoing vascular surgery for peripheral arterial disease. [29] [30] [31] Similar to black patients with peripheral arterial disease, black patients undergoing CEA were younger and more likely to be female compared with white CEA patients, potentially explaining their overall better long-term survival.
Although we accounted for these variables in our models, residual confounding likely remained. Several limitations are inherent to this study, and our results must be interpreted accordingly. First, we performed a retrospective analysis of prospectively collected data. This design does not obviate bias as a randomized trial would. However, we were able to partially account for this by our large sample size, which allowed adjusted analysis. Second, the predefined variables captured by the VQI precluded additional detailed analysis based on socioeconomic factors, such as ZIP codes, or on hospital type, as these were not captured. In addition, the deidentification of the data prevented any geographic analysis. Despite these limitations, we present a large contemporary cohort of CEA patients, which allowed adjusted analysis into the impact of race on both perioperative and long-term outcomes.
CONCLUSIONS
Despite widespread racial disparities in comorbidities, vascular risk factors, insurance status, hospital and surgeon quality, time to surgery after index neurologic symptom, patch angioplasty, and discharge medication among patients undergoing CEA, rates of perioperative stroke or death as well as unadjusted long-term survival were comparable between black and white patients. Moreover, after adjustment, which in part accounted for the identified disparities in vascular risk factors and surgical care, black patients experienced better longterm survival compared with white patients. Further research should be directed at understanding the underpinnings of these racial inequities. 
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